Sugammadex versus neostigmine in pediatric patients: A prospective randomized study;Sugammadex versus neostigmina em pacientes pediátricos: Estudo prospectivo e randomizado

Brazilian Journal of Anesthesiology

Volumn 64, Issue 6, 2014, Pages 400-405

  Kara, Turhan ^a   Ozbagriacik, Ozgur ^a   Turk, Hacer Sebnem ^a   Isil, Canan Tulay ^a   Gokuc, Ozan ^a   Unsal, Oya ^a   Seyhan, Emrah ^a   Oba, Sibel ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Neostigmine; Pediatric; Sugammadex

Indexed keywords

NEOSTIGMINE; ROCURONIUM; SUGAMMADEX;

AMBULATORY SURGERY; ARTICLE; CHILD; CONTROLLED STUDY; EXTUBATION; HUMAN; MAJOR CLINICAL STUDY; NEUROMUSCULAR BLOCKING; PEDIATRICS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 85027943228     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1016/j.bjan.2014.03.001     Document Type: Article

References (26)

1. Naguib M., Kopman A.F., Ensor J.E. Neuromuscular monitoring and postoperative residual curarization: a meta-analysis. Br J Anaesth 2007, 98:302-316.
2. Murphy G.S., Szokol J.W., Marymont J.H., et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008, 107:130-137.
3. Naguib M. Pharmacology of muscle relaxant and their antagonist neuromuscular physiology and pharmacology. Anaesthesia 2006, 481-572. Churchill Livingston, Philadelphia. 6th ed. R.D. Miller (Ed.).
4. Makri I., Papadima A., Lafioniati A., et al. Sugammadex, a promising reversal drug. A review of clinical trials. Rev Recent Clin Trials 2011, 6:250-255.
5. Srivastava A., Hunter J.M. Reversal of neuromuscular block. Br J Anaesth 2009, 103:115-129.
6. Sparr H.J., Booij L.H., Fuchs-Buder T. Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium. Anaesthesist 2009, 58:66-80.
7. Cope T.M., Hunter J.M. Selecting neuromuscular blocking drugs for elderly patients. Drugs Aging 2003, 20:125-140.
8. Meretoja O.A. Neuromuscular block and current treatment strategies for its reversal in children. Paediatr Anaesth 2010, 20:591-604.
9. Plaud B., Meretoja O., Hofmockel R., et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology 2009, 110:284-294.
10. Bevan D.R. Neuromuscular blocking drugs: onset and intubation. J Clin Anesth 1997, 9:36-39.
11. Fortier L.P., Robitaille R., Donati F. Increased sensitivity to depolarization and nondepolarizing neuromuscular blocking agents in young rat hemidiaphragms. Anesthesiology 2001, 95:478-484.
12. Vuksanaj D., Fisher D.M. Pharmacokinetics of rocuronium in children aged 4-11 years. Anesthesiology 1995, 82:1104-1110.
13. Vuksanaj D., Skjonsby B., Dunbar B.S. Neuromuscular effects of rocuronium in children during halothane anaesthesia. Paediatr Anaesth 1996, 6:277-281.
14. Fuchs-Buder T., Fink H., Hofmockel R., et al. Application of neuromuscular monitoring in Germany. Anaesthesist 2008, 57:908-914.
15. Padjama D., Mantha S. Monitoring of neuromuscular junction. Indian J Anaest 2002, 46:179-288.
16. D de Boer H. Sugammadex: a new challenge in neuromuscular management. Anesthesiol Crit Care 2009, 24:20-25.
17. Abrishami A., Ho J., Wong J., et al. Sugammadex: a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database Syst Rev 2009, 7:CD007362.
18. Jones R.K., Caldwell J.E., Brull S.J., et al. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. Anesthesiology 2008, 109:816-824.
19. Plaud B. Sugammadex: something new to improve patient safety or simply a gadget?. Ann Fr Anesth Reanim 2009, 28:64-69.
20. Sorgenfrei I.F., Norrild K., Larsen P.B., et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: dose finding and safety study. Anesthesiology 2006, 104:667-674.
21. Schaller S.J., Fink H., Ulm K., et al. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010, 113:1054-1060.
22. Hogg R.M., Mirakhur R.K. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block. Expert Rev Neurother 2009, 9:599-608.
23. Debaene B., Meistelman C. Indications and clinical use of sugammadex. Ann Fr Anesth Reanim 2009, 28:57-63.
24. Khuenl-Brady K.S., Wattwil M., Vanacker B.F., et al. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: multicentre, randomized controlled triad. Anesth Analg 2010, 110:64-73.
25. Blobner M., Eriksson L.I., Scholz J., et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010, 27:874-881.
26. Della Rocca G., Pompei L. A novel approach to reversal of neuromuscular blockade. Minerva Anestesiol 2009, 75:349-351.